Business
Great Point Partners Acquires a Majority Stake in Lenis Group, a Full-Service Specialty Pharmaceutical Commercialization and Distribution Partner
GREENWICH, Conn. & LJUBLJANA, Slovenia, December 10, 2025--Great Point Partners ("GPP" or "the Firm"), a Greenwich-based private investment firm focused exclusively on the healthcare industry, today announced that it has acquired a majority stake in Lenis Group ("Lenis" or "the Company"), a fast-growing Slovenian-based full-service regional commercialization and distribution partner for niche and specialty Rx medicines in Central and Eastern Europe ("CEE").
About this update from Biogen Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1000,"height":254,"url":"https://media.zenfs.com/en/business-wire.com/7b38c7343830ccf0335c958b574ef1f6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6lmUrv2A8iYUM2vk3x1mgw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/7b38c7343830ccf0335c958b574ef1f6","width":960,"height":244},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/bceJpLKk2u9emdWnDWi_yw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwMDA7aD01MDg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/7b38c7343830ccf0335c958b574ef1f6","width":1000,"height":254}},"lazy":false},{"type":"text","content":"Former CEO of Biogen, Michel Vounatsos, Appointed Board Chairman of Lenis","length":73,"tagName":"p","attribs":{}},{"type":"text","content":"GREENWICH, Conn. & LJUBLJANA, Slovenia, December 10, 2025--(BUSINESS WIRE)--Great Point Partners ("GPP" or "the Firm"), a Greenwich-based private investment firm focused exclusively on the healthcare industry, today announced that it has acquired a majority stake in Lenis Group ("Lenis" or "the Company"), a fast-growing Slovenian-based full-service regional commercialization and distribution partner for niche and specialty Rx medicines in Central and Eastern Europe ("CEE").","length":532,"tagName":"p"},{"type":"text","content":"Founded in 2008, Lenis has become a trusted partner to biotechnology and pharmaceutical companies across the highly complex but rapidly growing CEE region, covering the entire product lifecycle – from early access and pre-launch, through launch and growth, to mature lifecycle management.","length":288,"tagName":"p"},{"type":"text","content":"The Company is recognized for its strong compliance culture, market access and reimbursement capabilities, regulatory expertise, and high-quality medical and marketing functions, enabled by its direct CEE presence and embedded cross-functional teams. In local markets, Lenis is an important stakeholder in ensuring the continuous availability of critical therapies, working in close collaboration with healthcare institutions and professionals, regulatory authorities, NGOs and patient organizations.","length":500,"tagName":"p"},{"type":"text","content...